Skip to ContentSkip to Navigation
founded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons prof. dr. H.J. (Henkjan) Verkade
University Medical Center Groningen

prof. dr. H.J. (Henkjan) Verkade

Hoogleraar Kindergeneeskunde / Maag-, Darm- en Leverziekten

Publicaties

Back to basics: Bile acids in fat absorption

Bile acid detergency as determinant of liver pathology in a humanized mouse model of progressive familial intrahepatic cholestasis type 3

Bile Acid Detergency as Determinant of Liver Pathology in a Humanized Mouse Model of Progressive Familial Intrahepatic Cholestasis Type 3

Breastmilk and medium-chain triglyceride supplementation: Retrospective study on outcomes in biliary atresia infants after Kasai

Farnesoid x Receptor Deficiency Promotes Hepatocytic Injury in Cyp2c70-Deficient Mice With a Human-Like Bile Acid Composition

FGF1 ameliorates hepatic steatosis through acute activation of the unfolded protein response and VLDL production

Generation and characterization of a mouse model for bile salt export pump deficiency with the p.E297G mutation

Ileal bile acid transporter inhibitors in Alagille syndrome and Progressive Familial Intrahepatic Cholestasis: A systematic review into dose-response

Odevixibat treatment for recurrent cholestasis in a patient with biallelic UNC45A variants causing osteo-oto-hepato-enteric syndrome

Absence of Pupillary Reflexes in Pediatric Acute Liver Failure and Neurological Outcome After Liver Transplantation

Pers/media

Drugs, approval in the EU of 2 new therapies for rare cholestatic diseases

Ipsen crosses EU finish line with Alagille syndrome drug

Ipsen’s Kayfanda® Approved in European Union for Rare Liver Disease

Malattie colestatiche rare: il CHMP esprime parere positivo su due nuove molecole